secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGM Biosciences, Inc. (—)
CIK:        0001496323
Form:       8-K
Filed at:   2023-03-21T23:59:59+00:00
Accession:  0000950170-23-008939
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IGM Biosciences amends bylaws to update proxy, stockholder meeting procedures
-----------------------------------------------------------------------------

- Bylaws amended effective March 16, 2023 to align with universal proxy rules and DGCL changes.
- Updated advance notice procedures for director nominations and stockholder proposals, including Rule 14a-19 compliance.
- Requires additional disclosures on related party transactions and third-party compensation for director nominees.
- Board gains explicit authority to cancel, postpone, or reschedule annual and special stockholder meetings.
- Changes conform to recent amendments to the Delaware General Corporation Law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1496323/000095017023008939/0000950170-23-008939-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1496323/000095017023008939/igms-20230316.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-008939

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer